What is cancer diagnostics?

The global cancer burden is increasing. Cancer diagnostics or lab tests used in cancer diagnosis range from tissue-based tests to molecular testing. With precision oncology entering mainstream care, more patients are undergoing biomarker testing in order to access more targeted and effective therapies. Today, a wide range of cancer in vitro diagnostics (IVD) tests are available, including immunoassays, tissue-based tests, PCR-based molecular diagnostics, liquid biopsy and next generation sequencing (NGS).

Clearstate offers market data, forecasts, and trend predictions to give you insight on the fast-growing cancer diagnostics market.

Cancer diagnostics updates

Cancer diagnostics updates

Our cancer diagnostics hub is regularly updated to share our findings on this IVD market segment that is experiencing strong growth. 

Explore the latest diagnostic innovations which are opening up new possibilities for cancer testing and treatment.

What are the infrastructure, reimbursement levels, affordability and availability of cancer IVDs that influence the access to cancer IVDs in each country or region? How is the patient journey for cancer diagnosis and treatment using biomarkers changing? What are the top cancer biomarkers and test strategies?

Discover more IVD insights and learn how our IVD Gateway solution can help prepare your business to support the drive to integrate the use of IVDs into regional or national plans to fight cancer.

Explore how Clearstate can enable your business to grow in the market, inquire now.

Explore the latest cancer diagnostics market insights 

From market news to analysis, our articles provide concise and up-to-date information about the current state of cancer diagnostics and the impact of developments such as a growing global cancer burden and the rise of precision care on the future of cancer IVDs. Uncover the challenges and opportunities ahead as laboratories play a key role in combating the rising global cancer burden. Learn from leading experts and analysts, and see real-world examples of laboratories and clinicians using cancer diagnostics to improve cancer care.

Understand the cancer diagnostics market 

In order to determine the future outlook of the cancer diagnostics market, we must first understand and integrate macro insights on population trends, epidemiology, reimbursement, local affordability levels, testing landscape. Our reports show how and where businesses can capture opportunities as healthcare systems and laboratories seek out greater access to cancer diagnostics.

Clearstate newsletter

Sign up to our newsletter for insights into key market data, trends and developments across IVD and Surgical segments from our specialists and analysts.